CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY) Given Average Rating of “Hold” by Brokerages

Shares of CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOYGet Free Report) have been assigned an average rating of “Hold” from the six research firms that are currently covering the stock, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a hold recommendation and one has given a strong buy recommendation to the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is $117.00.

Several research analysts have recently issued reports on CHEOY shares. Jefferies Financial Group downgraded CochLear from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, July 22nd. Zacks Research raised shares of CochLear from a “strong sell” rating to a “hold” rating in a report on Monday, June 22nd. Royal Bank Of Canada cut shares of CochLear from an “outperform” rating to a “sector perform” rating and set a $117.00 price objective for the company. in a research note on Thursday, July 16th. Finally, UBS Group lowered CochLear from a “strong-buy” rating to a “hold” rating in a research note on Thursday, April 23rd.

Check Out Our Latest Stock Report on CHEOY

CochLear Price Performance

CochLear stock opened at $48.27 on Friday. CochLear has a fifty-two week low of $31.82 and a fifty-two week high of $104.65. The stock’s fifty day moving average is $42.39 and its two-hundred day moving average is $50.68.

CochLear Company Profile

(Get Free Report)

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

Featured Stories

Analyst Recommendations for CochLear (OTCMKTS:CHEOY)

Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.